sec filing
TA
NASDAQ · TARA
Protara Therapeutics, Inc.
Healthcare · Biotechnology
$2.48
Down-$0.04 (-1.59%)
Updated Nov 1, 2026, 10:39 PM
SID Score
3.0/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 231.52M
- P/E ratio
- -4.99
- Dividend yield
- 0.00%
- 52-week range
- $2.28 – $7.82
- Volume
- 581.16K
- Avg. volume
- 762.46K
Price performance · TARA
TARA price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 30, 2026
TARA closed at $2.48 after 20 trading sessions, down 5.70% for the selected period.
- Last close
- $2.48
- Period change
- -5.70%
- Period low
- $2.32
- Period high
- $2.77
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 30, 2026 | $2.51 | $2.57 | $2.43 | $2.48 | 581.16K |
| Oct 29, 2026 | $2.52 | $2.625 | $2.50 | $2.52 | 553.34K |
| Oct 28, 2026 | $2.45 | $2.515 | $2.365 | $2.49 | 1.21M |
| Oct 27, 2026 | $2.33 | $2.48 | $2.31 | $2.47 | 1.84M |
| Oct 26, 2026 | $2.35 | $2.43 | $2.305 | $2.35 | 892.65K |
| Oct 23, 2026 | $2.39 | $2.47 | $2.28 | $2.33 | 867.58K |
| Oct 22, 2026 | $2.47 | $2.525 | $2.42 | $2.44 | 1.76M |
| Oct 21, 2026 | $2.57 | $2.61 | $2.49 | $2.50 | 971.16K |
| Oct 20, 2026 | $2.34 | $2.575 | $2.33 | $2.56 | 1.5M |
| Oct 19, 2026 | $2.35 | $2.43 | $2.295 | $2.33 | 1.18M |
| Oct 16, 2026 | $2.38 | $2.465 | $2.32 | $2.32 | 1.17M |
| Oct 15, 2026 | $2.51 | $2.5578 | $2.375 | $2.40 | 861.83K |
| Oct 14, 2026 | $2.60 | $2.6589 | $2.47 | $2.48 | 705.52K |
| Oct 13, 2026 | $2.77 | $2.83 | $2.615 | $2.62 | 930.33K |
| Oct 12, 2026 | $2.75 | $2.79 | $2.705 | $2.77 | 1.08M |
| Oct 9, 2026 | $2.69 | $2.785 | $2.65 | $2.755 | 1.04M |
| Oct 8, 2026 | $2.59 | $2.69 | $2.515 | $2.65 | 1.22M |
| Oct 7, 2026 | $2.54 | $2.67 | $2.51 | $2.59 | 731.35K |
| Oct 6, 2026 | $2.63 | $2.70 | $2.53 | $2.555 | 803.56K |
| Oct 5, 2026 | $2.71 | $2.72 | $2.565 | $2.63 | 1.4M |
Latest TARA news
The latest Smart Investors Daily articles mentioning TARA.
Stock researchCompany · Financials
Company
Market Activity
Research & News
Loading stock research…

